ReviewTranslational lung cancer research2026

The resistance landscape of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer: molecular mechanisms and novel therapeutic strategies.

Shuotong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.